Yoshioka K, Kakumu S, Tahara H, Arao M, Fuji A, Hirofuji H, Hayashi T, Kano H
Third Department of Medicine, Nagoya University School of Medicine, Japan.
Am J Gastroenterol. 1989 May;84(5):535-9.
To determine the diagnostic significance of immunohistochemically detected small Mallory bodies (MBs) which are invisible by conventional stainings, we investigated the occurrence of MBs in liver tissue with alcoholic and nonalcoholic liver disease by immunoperoxidase staining with monoclonal anti-MB antibody, anti-NMB-3. In conventional stainings, MBs were detected in only six of 26 (23%) patients with alcoholic liver disease, and nine of 63 (14%) patients with nonalcoholic liver disease. On the other hand, MBs were detected in 20 of 26 (77%) patients with alcoholic liver disease, and 25 of 63 (40%) patients with nonalcoholic liver disease by immunoperoxidase staining. Immunohistochemically detected MBs were shown to possess the ultrastructural characteristics of MBs by immunoelectronmicroscopy in the four specimens. Our result indicates that the small MBs are not rare in nonalcoholic liver disease, and the presence of immunohistochemically detected small MBs is not a good marker of an alcoholic etiology.
为了确定免疫组化检测到的常规染色不可见的小马洛里小体(MBs)的诊断意义,我们通过用单克隆抗MB抗体抗-NMB-3进行免疫过氧化物酶染色,研究了酒精性和非酒精性肝病肝组织中MBs的出现情况。在常规染色中,26例酒精性肝病患者中仅6例(23%)检测到MBs,63例非酒精性肝病患者中9例(14%)检测到MBs。另一方面,通过免疫过氧化物酶染色,26例酒精性肝病患者中有20例(77%)检测到MBs,63例非酒精性肝病患者中有25例(40%)检测到MBs。通过免疫电子显微镜在四个标本中显示,免疫组化检测到的MBs具有MBs的超微结构特征。我们的结果表明,小MBs在非酒精性肝病中并不罕见,免疫组化检测到的小MBs的存在并不是酒精性病因的良好标志物。